variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
PRODH-L441P,PRODH,"Causes hyperprolinemia in a recessive manner (high levels of proline in the blood due to a defect in metabolism of this amino acid). This can sometimes lead to seizures, mental retardation, and other neurological manifestations. Some authors also hypothesize hyperprolinemia is a risk factor for schizophrenia, but this is less well supported and the effect of this variant on risk for that disease is unclear.",High,Well-established,Pathogenic,0.0059,Blood;Mental and behavioral;Metabolism;Nervous system,Recessive,Heterozygous,12217952;15662599,rs2904551,5,chr22,18905934,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
PKD1-R4276W,PKD1,"Reported to cause autosomal dominant polycystic kidney disease, but it has been seen in a confirmed-healthy PGP participant and one other presumed-healthy control genome (overall frequency in randomly chosen controls is 1.7%).",High,Uncertain,Pathogenic,0.002,Genital and urinary,Dominant,Heterozygous,10200984,rs114251396,5,chr16,2139814,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
RP1-T373I,RP1,"Reported to cause recessive retinitis pigmentosa in some Pakistani families. Because it is unclear whether these families have some common ancestry, and because there may be an uncharacterized linked variant, this pathogenic effect of this variant is considered uncertain.",High,Uncertain,Pathogenic,0.012,Hearing and vision,Recessive,Heterozygous,11095597;15863674,rs77775126,5,chr8,55537560,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
VWF-R854Q,VWF,Causes type 2N von Willebrand disease in a recessive manner. This defect in coagulation can manifest as excessive bleeding during surgery.,Moderate,Likely,Pathogenic,0.0041,Other,Recessive,Heterozygous,22875612,rs41276738,5,chr12,6143978,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Homozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
HFE-H63D,HFE,"There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.",Low,Uncertain,Pathogenic,0.11,Blood,Recessive,Heterozygous,8696333;9462220;12429850;14673107;17042772,rs1799945,1,chr6,26091179,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
ELAC2-A541T,ELAC2,"This variant is implicated as causing increased susceptibility to prostate cancer. However the variant has always been seen paired with S217L, it is unclear which variant is causal. Evidence is weak for both; one meta-analysis (Severi et al.) concluded that neither variant was pathogenic, a more recent meta-analysis (Xu et al.) found the data to be significant but the odds ratio was not strong and concluded they are ""low-penetrance susceptibility markers of prostate cancer"".",Low,Uncertain,Pathogenic,0.028,Cancer;Genital and urinary,Unknown,Heterozygous,10986046;11175785;11431329;12373607;12515253;12783937;18767027;20231859,rs34152967,2,chr17,12899902,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Heterozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
ARSA-N350S,ARSA,This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.,Low,Well-established,Benign,0.18,Other,Unknown,Heterozygous,2574462,rs2071421,,chr22,51064416,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
FLT4-N149D,FLT4,"Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.",Low,Likely,Benign,0.073,Blood,Unknown,Heterozygous,11292664,rs34221241,,chr5,180057293,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
PKD1-A4059V,PKD1,Probably benign.,Low,Likely,Benign,0.057,Other,Unknown,Heterozygous,19686598,rs3209986,,chr16,2140554,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Homozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
GJB3-R32W,GJB3,"Probably benign. Although Polyphen 2 predicts it be damaging and some publications suggested it might have a functional effect, others report it to be a fairly common polymorphism and functional studies failed to find a difference between it and wild type.",Low,Uncertain,Benign,0.022,Other,Unknown,Heterozygous,10888284;11175305;12702148,rs1805063,,chr1,35250457,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
RPGRIP1L-A1183G,RPGRIP1L,"Probably not pathogenic, although it may have a modifier effect in other diseases. Other disruptive variants in this gene are implicated in causing Joubert Syndrome and Meckel Syndrome in a recessive manner. Although this variant is somewhat rare (1.1% allele frequency) and Polyphen 2 predicts it to be disruptive, most reported disease-causing variants in the gene are more disruptive frameshift or nonsense mutations & occur upstream of this position.",Low,Uncertain,Benign,0.011,Anatomical and congenital;Mental and behavioral;Nervous system,Unknown,Heterozygous,19430481,,,chr16,53653005,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
ELN-G581R,ELN,"Probably a benign SNP, not rare (4.8% allele frequency in GET-Evidence data).",Low,Uncertain,Benign,0.073,Other,Unknown,Homozygous,,rs17855988,,chr7,73474825,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
PHYH-P29S,PHYH,"Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.",Low,Uncertain,Benign,0.16,Nervous system,Unknown,Heterozygous,10767344;14974078,rs28938169,0,chr10,13340236,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Homozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3d435cb30c9679d082ce122f07deacf01a704b4a&access_token=42dc81538c4d03915535d90af1cd9f3e
